Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcription–replication conflicts underlie sensitivity to PARP inhibitors
Michalis Petropoulos, Angeliki Karamichali, Giacomo G. Rossetti, et al.
Nature (2024) Vol. 628, Iss. 8007, pp. 433-441
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality
Xin Li, Lee Zou
Journal of Clinical Investigation (2024) Vol. 134, Iss. 14
Open Access | Times Cited: 13
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours
Diego Dibitetto, Martin Liptay, Francesca Vivalda, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
PARPi, BRCA, and gaps: controversies and future research
Diego Dibitetto, Carmen A. Widmer, Sven Rottenberg
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 857-869
Open Access | Times Cited: 10
Mechanism for local attenuation of DNA replication at double-strand breaks
Robin Sebastian, Eric G. Sun, Michael Fedkenheuer, et al.
Nature (2025)
Closed Access | Times Cited: 1
(Single-stranded DNA) gaps in understanding BRCAness
Anne Schreuder, Tiemen J. Wendel, Carlo G.V. Dorresteijn, et al.
Trends in Genetics (2024) Vol. 40, Iss. 9, pp. 757-771
Open Access | Times Cited: 5
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Marina Kolesnichenko, Claus Scheidereit
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Update on Combination Strategies of PARP Inhibitors
Zhuoqun Lin, Lingfang Wang, Ziyu Xing, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 4
HIRA protects telomeres against R-loop-induced instability in ALT cancer cells
Michelle Lee Lynskey, Emily Brown, Ragini Bhargava, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114964-114964
Closed Access | Times Cited: 4
Chromatin-centric insights into DNA replication
Yang Liu, Zhengrong Zhangding, Xuhao Liu, et al.
Trends in Genetics (2025)
Closed Access
Gradient experiment reveals physiological stress from heavy metal zinc on the economically valuable seaweed Sargassum fusiforme
Yangfu Kuang, Dongmei Bao, Xingda Sheng, et al.
Marine Environmental Research (2025) Vol. 204, pp. 106958-106958
Closed Access
Development of 99mTc-Labeled Complexes with a Niraparib HYNIC Derivative for PARP-Positive Tumor Imaging
Qianna Wang, Junhong Feng, Yuhao Jiang, et al.
Molecular Pharmaceutics (2025)
Closed Access
Design, Synthesis, and Pharmacodynamic Evaluation of Highly Selective PARP1 Inhibitors with Brain Penetrance
Tao Guo, Yongting Yuan, Yurong Zou, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Reversing Regulatory Safeguards: Targeting the ATR Pathway to Overcome PARP Inhibitor Resistance
Xixi Lin, Yongchang Qiu, Aashish Soni, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200934-200934
Open Access
PARP inhibition-associated heterochromatin confers increased DNA replication stress and vulnerability to ATR inhibition in SMARCA4-deficient cells
Kimiyoshi Yano, Megumi Kato, Satoshi Endo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Nuclear ANLN regulates transcription initiation related Pol II clustering and target gene expression
Yu-Fei Cao, Hui Wang, Yonghua Sun, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
ATP-Dependent Chromatin Remodeler CSB Couples DNA Repair Pathways to Transcription with Implications for Cockayne Syndrome and Cancer Therapy
Rabeya Bilkis, Robert J. Lake, Hua-Ying Fan
Cells (2025) Vol. 14, Iss. 4, pp. 239-239
Open Access
TIPIN is essential for chromosome stability and cell viability in BRCA1-deficient cells
Takuya Abe, Yui Yoshimoto, Seiya Matsuno, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 752, pp. 151467-151467
Open Access
‘Where is my gap’: mechanisms underpinning PARP inhibitor sensitivity in cancer
Lauryn Buckley-Benbow, Alessandro Agnarelli, Roberto Bellelli
Biochemical Society Transactions (2025) Vol. 53, Iss. 01
Open Access
Olaparib reverses prostate cancer resistance to Rapamycin by promoting macrophage polarization towards the M1 phenotype
Kai Ye, Gang Shi, Jian Xu, et al.
Molecular and Cellular Biochemistry (2025)
Open Access
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers
Sarah C. Moser, Jos Jonkers
Cancer Discovery (2025) Vol. 15, Iss. 3, pp. 461-480
Closed Access
Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies
Jinshou Yang, Feihan Zhou, Xiyuan Luo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
R-loop homeostasis in genome dynamics, gene expression and development
Paula Aguilera, Andrés Aguilera
Current Opinion in Genetics & Development (2025) Vol. 92, pp. 102325-102325
Closed Access
KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
Lena Lau, Kurt Henderson, Ahu Turkoz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer
Jinge Zhao, Bo Tang, Pengfei Shen, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104698-104698
Closed Access
Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine
Cheng Wang, Xiaoran Han, Shaoqiu Kong, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117955-117955
Closed Access
Page 1 - Next Page

Scroll to top